ACAD ACADIA Pharmaceuticals Inc. - Common Stock
$29,17
Preço · Ago 18, 2026
Fundamentais a partir de Ago 5, 2026
Intervalo 52 Semanas
$20–$30
93% of range
Classificação do Analista
BUY
27 analysts
Preço-Alvo
$34
+16% upside
P/E (TTM)
12.7
ROE
38.1%
Margem de Lucro Líquido
36.5%
Sobre ACADIA Pharmaceuticals Inc. - Common Stock Visão geral da empresa da Wikipedia
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Ler mais
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
ACAD Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$29.17
Capitalização de Mercado
$4.97B
P/E (TTM)
12.7
EPS (TTM)
$2.30
Receita (TTM)
$1.07B
Rendimento div.
—
ROE
38.1%
Dívida/Capital
—
Intervalo 52 Semanas
$20 – $30
ACAD Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$1.07B
2016-12-31
→
2025-12-31
EPS
$2.30
2020-12-31
→
2025-12-31
Fluxo de caixa livre
$105M
2016-12-31
→
2025-12-31
Margens
36.5%
2016-12-31
→
2023-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
ACAD
Mediana de Pares
P/E (TTM)
12.7
13.2
P/S (TTM)
4.6
55.3
P/B
4.0
3.5
Price / FCF (Preço / FCF)
47.2
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
ACAD
Mediana de Pares
Operating Margin (Margem Operacional)
9.8%
—
Net Profit Margin (Margem de Lucro Líquido)
36.5%
-151.2%
ROA
28.4%
-42.2%
ROE
38.1%
-52.8%
ROIC
24.0%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
ACAD
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
3.8
10.3
Quick Ratio (Índice de Liquidez Seca)
1.1
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
ACAD
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
11.9%
—
Revenue CAGR 3Y (CAGR Receita 3A)
27.5%
—
Revenue CAGR 5Y (CAGR Receita 5A)
19.4%
—
EPS YoY
69.1%
—
Net Income YoY (Lucro Líquido Ano a Ano)
72.7%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
ACAD
Mediana de Pares
ACAD Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
27 analistas
- Compra forte 7 25,9%
- Compra 14 51,9%
- Manter 5 18,5%
- Venda 1 3,7%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
20 analistas · 2026-08-18
Mediana
$36.00
Agora
$29.17
Mín
$17.00
Máx
$49.00
Alvo mediano
$36.00
+23,4%
Alvo médio
$33.85
+16,0%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.30%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $0.18 | $0.06 | 0.12% |
| 31 de Março de 2026 | $0.02 | $0.06 | -0.04% |
| 31 de Dezembro de 2025 | $1.60 | $0.14 | 1.5% |
| 30 de Setembro de 2025 | $0.42 | $0.15 | 0.27% |
| 30 de Junho de 2025 | $0.16 | $0.14 | 0.02% |
| 31 de Março de 2025 | $0.11 | $0.11 | -0.00% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
| PBLS | — | — | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
Balanço Patrimonial 25
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
Fluxo de Caixa 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
Taxas de Crescimento 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
Demonstração de Resultados 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | -335,115,000 | 168,836,000 | 167,827,000 | 166,808,000 | -330,606,000 | 165,974,000 | 165,551,000 | 164,798,000 | -326,136,000 | 164,234,000 | 163,458,000 | 162,263,000 | 128,494 | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | -337,080,000 | 170,650,000 | 168,681,000 | 167,668,000 | -332,613,000 | 166,178,000 | 166,174,000 | 166,623,000 | -327,724,000 | 164,234,000 | 165,046,000 | 162,263,000 | 128,494 | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
Balanço Patrimonial 24
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $1.06B | · | $1.04B | $1.00B | $943M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $134M | $121M | · | $150M | $112M | $102M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 32.4 | 31.4 | · | 24.0 | 32.2 | 27.2 | · | 19.7 | 90.3 | -1849.0 | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.9 | 3.6 | · | 3.5 | 3.6 | 2.9 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| P / FCF | · | 132.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | · | 4.2% | 3.1% | 3.7% | · | 5.1% | 1.1% | -0.05% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $1.07B | $958M | $726M | $517M | $484M |
| Margem Bruta % | — | — | 94.3% | 98.0% | 97.8% |
| Margem Operacional % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| Lucro líquido | $391M | $226M | $-61M | $-216M | $-168M |
| EPS Diluído | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| Índice de Liquidez Seca | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $105M | $157M | $17M | $-114M | $-127M |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 387 declarantes · $3.2B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 56 (+10 vs trimestre anterior) | 37 (+10 vs trimestre anterior) | 136 (+11 vs trimestre anterior) | 100 (-13 vs trimestre anterior) | +17.3M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1.085.696.471 | 42.912.904 | 33,44% | Ações |
| STATE STREET CORP | $229.628.164 | 9.076.212 | 7,07% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223.612.785 | 8.838.450 | 6,89% | Ações |
| RTW INVESTMENTS, LP | $180.756.457 | 7.144.524 | 5,57% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $145.822.875 | 5.763.750 | 4,49% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $88.971.384 | 3.516.656 | 2,74% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $73.088.127 | 2.888.204 | 2,25% | Ações |
| Qube Research & Technologies Ltd | $61.899.233 | 2.446.610 | 1,91% | Ações |
| Point72 Asset Management, L.P. | $61.559.150 | 2.433.168 | 1,90% | Ações |
| CITADEL ADVISORS LLC | $53.414.195 | 2.111.233 | 1,65% | Ações |
| Pictet Asset Management Holding SA | $50.146.450 | 1.983.198 | 1,54% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49.826.959 | 1.969.445 | 1,53% | Ações |
| MARSHALL WACE, LLP | $44.649.289 | 1.764.794 | 1,38% | Ações |
| BRAIDWELL LP | $41.653.895 | 1.646.399 | 1,28% | Ações |
| NORGES BANK | $41.069.692 | 1.623.308 | 1,26% | Ações |
| Frazier Life Sciences Management, L.P. | $36.386.409 | 1.438.198 | 1,12% | Ações |
| Artisan Partners Limited Partnership | $33.525.890 | 1.325.134 | 1,03% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $32.449.679 | 1.282.596 | 1,00% | Ações |
| GOLDMAN SACHS GROUP INC | $32.070.584 | 1.267.612 | 0,99% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.520.301 | 1.206.336 | 0,94% | Ações |
| D. E. Shaw & Co., Inc. | $28.330.257 | 1.119.773 | 0,87% | Ações |
| Allspring Global Investments Holdings, LLC | $26.143.513 | 1.037.441 | 0,81% | Ações |
| TWO SIGMA INVESTMENTS, LP | $23.452.898 | 926.992 | 0,72% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $23.082.961 | 912.370 | 0,71% | Ações |
| BANK OF AMERICA CORP /DE/ | $21.702.062 | 857.789 | 0,67% | Ações |
| PANAGORA ASSET MANAGEMENT INC | $17.985.922 | 710.906 | 0,55% | Ações |
| Fisher Asset Management, LLC | $17.690.535 | 699.230 | 0,54% | Ações |
| Allianz Asset Management GmbH | $15.730.341 | 706.664 | 0,48% | Ações |
| RICE HALL JAMES & ASSOCIATES, LLC | $15.657.841 | 618.887 | 0,48% | Ações |
| MILLENNIUM MANAGEMENT LLC | $14.925.077 | 589.924 | 0,46% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14.771.456 | 583.852 | 0,45% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.903.000 | 510.000 | 0,40% | Ações |
| Hudson Bay Capital Management LP | $11.764.500 | 465.000 | 0,36% | Ações |
| GLENMEDE TRUST CO NA | $11.656.544 | 460.733 | 0,36% | Ações |
| JUPITER ASSET MANAGEMENT LTD | $11.599.190 | 458.466 | 0,36% | Ações |
| Public Sector Pension Investment Board | $11.014.988 | 435.375 | 0,34% | Ações |
| MACKENZIE FINANCIAL CORP | $10.646.872 | 420.825 | 0,33% | Ações |
| Ishara Investments LP | $10.373.000 | 410.000 | 0,32% | Ações |
| TWO SIGMA ADVISERS, LP | $9.888.042 | 370.200 | 0,30% | Ações |
| Balyasny Asset Management L.P. | $9.817.007 | 388.024 | 0,30% | Ações |
| BlackRock, Inc. | $9.281.482 | 366.857 | 0,29% | Ações |
| SPHERA FUNDS MANAGEMENT LTD. | $9.020.310 | 356.534 | 0,28% | Ações |
| AMERIPRISE FINANCIAL INC | $8.039.177 | 317.754 | 0,25% | Ações |
| PRUDENTIAL FINANCIAL INC | $7.985.313 | 315.625 | 0,25% | Ações |
| Alyeska Investment Group, L.P. | $7.850.261 | 310.287 | 0,24% | Ações |
| RHUMBLINE ADVISERS | $7.663.389 | 302.902 | 0,24% | Ações |
| Schonfeld Strategic Advisors LLC | $7.189.171 | 284.157 | 0,22% | Ações |
| Edgestream Partners, L.P. | $7.167.515 | 283.301 | 0,22% | Ações |
| Logos Global Management LP | $6.325.000 | 250.000 | 0,19% | Ações |
| LAZARD ASSET MANAGEMENT LLC | $6.263.496 | 247.569 | 0,19% | Ações |
| FMR LLC | $6.052.317 | 239.222 | 0,19% | Ações |
| Swiss National Bank | $5.841.871 | 230.904 | 0,18% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $5.432.213 | 214.712 | 0,17% | Ações |
| ALPS ADVISORS INC | $4.985.340 | 197.049 | 0,15% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $4.926.239 | 194.713 | 0,15% | Ações |
| Legal & General Group Plc | $4.918.245 | 194.397 | 0,15% | Ações |
| FIRST TRUST ADVISORS LP | $4.664.965 | 184.386 | 0,14% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $4.364.807 | 172.522 | 0,13% | Ações |
| Birchview Capital, LP | $4.326.300 | 171.000 | 0,13% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $4.247.693 | 167.893 | 0,13% | Ações |
| Tetragon Partners GP Ltd | $4.247.238 | 167.875 | 0,13% | Ações |
| GREAT LAKES ADVISORS, LLC | $3.822.526 | 151.088 | 0,12% | Ações |
| AMERICAN CENTURY COMPANIES INC | $3.635.306 | 143.688 | 0,11% | Ações |
| STEMPOINT CAPITAL LP | $3.622.125 | 143.167 | 0,11% | Ações |
| ALLIANCEBERNSTEIN L.P. | $3.585.329 | 161.066 | 0,11% | Ações |
| Squarepoint Ops LLC | $3.542.329 | 140.013 | 0,11% | Ações |
| ORBIMED ADVISORS LLC | $3.466.100 | 137.000 | 0,11% | Ações |
| Erste Asset Management GmbH | $3.369.240 | 133.700 | 0,10% | Ações |
| Emerald Investment Advisers, LLC | $3.333.326 | 131.752 | 0,10% | Ações |
| Caption Management, LLC | $3.289.000 | 130.000 | 0,10% | Opção de venda |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.130.217 | 123.724 | 0,10% | Ações |
| WELLS FARGO & COMPANY/MN | $3.084.475 | 121.916 | 0,09% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.077.311 | 138.244 | 0,09% | Ações |
| Longaeva Partners L.P. | $2.968.145 | 117.318 | 0,09% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.948.791 | 116.553 | 0,09% | Ações |
| Trexquant Investment LP | $2.935.357 | 116.022 | 0,09% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2.909.778 | 115.011 | 0,09% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $2.868.477 | 113.289 | 0,09% | Ações |
| Rafferty Asset Management, LLC | $2.789.426 | 110.254 | 0,09% | Ações |
| Nan Fung Group Holdings Ltd | $2.605.495 | 102.984 | 0,08% | Ações |
| RAYMOND JAMES FINANCIAL INC | $2.406.232 | 95.108 | 0,07% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.344.000 | 92.648 | 0,07% | Ações |
| ROYCE & ASSOCIATES LP | $2.324.691 | 91.885 | 0,07% | Ações |
| HOHIMER WEALTH MANAGEMENT, LLC | $2.322.540 | 91.800 | 0,07% | Ações |
| Point72 Europe (London) LLP | $2.305.047 | 108.015 | 0,07% | Ações |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2.134.076 | 79.898 | 0,07% | Ações |
| Campbell & CO Investment Adviser LLC | $2.108.527 | 83.341 | 0,06% | Ações |
| Verdad Advisers, LP | $2.090.514 | 82.629 | 0,06% | Ações |
| VOYA INVESTMENT MANAGEMENT LLC | $2.072.576 | 81.920 | 0,06% | Ações |
| CITADEL ADVISORS LLC | $2.049.300 | 81.000 | 0,06% | Opção de compra |
| GUGGENHEIM CAPITAL LLC | $1.979.776 | 78.252 | 0,06% | Ações |
| WESBANCO BANK INC | $1.978.460 | 78.200 | 0,06% | Ações |
| Phocas Financial Corp. | $1.954.299 | 77.245 | 0,06% | Ações |
| MetLife Investment Management, LLC | $1.899.043 | 75.061 | 0,06% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.850.493 | 73.142 | 0,06% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.788.331 | 70.685 | 0,06% | Ações |
| Freestone Grove Partners LP | $1.755.643 | 69.393 | 0,05% | Ações |
| CenterBook Partners LP | $1.743.878 | 68.928 | 0,05% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $1.722.930 | 68.100 | 0,05% | Ações |
| Illinois Municipal Retirement Fund | $1.693.380 | 66.932 | 0,05% | Ações |
Executivos da empresa 37 insiders · 19 diretores · 19 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Stephen Davis | CEO | 6 de Janeiro de 2024 M | 96.521 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 25 de Março de 2011 A | 69.916 | 0 | 0 | $0 |
| Elena Ridloff | EVP and CFO | 29 de Abril de 2021 M | 10.553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 15 de Outubro de 2018 A | — | 0 | 0 | $0 |
| Thomas H Aasen | Exec. VP, CFO & CBO | 25 de Março de 2011 A | 13.899 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 21 de Novembro de 2022 M | 61.234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 16 de Junho de 2006 S | 317.756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, Head of Commercial | 6 de Janeiro de 2024 M | 30.949 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 29 de Julho de 2026 M | 18.994 | 0 | 2 | $-432.662 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 26 de Junho de 2026 S | 13.088 | 0 | 2 | $-412.253 |
| Austin D. Kim | EVP,General Counsel, Secretary | 6 de Janeiro de 2024 M | 46.901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 10 de Fevereiro de 2023 A | — | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 6 de Janeiro de 2021 M | 8.059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 15 de Outubro de 2019 M | 270 | 0 | 0 | $0 |
| Glenn Baity | VP, GC & Sec. | 25 de Março de 2011 A | — | 0 | 0 | $0 |
| Roger Mills | Executive VP, Development | 25 de Março de 2011 A | — | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 8 de Julho de 2009 M | 20.000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 7 de Março de 2008 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 11 de Março de 2005 A | — | 0 | 0 | $0 |
| Adora Ndu | Conselheiro | 29 de Maio de 2026 A | 32.908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | Conselheiro | 29 de Maio de 2026 A | 33.489 | 0 | 0 | $0 |
| Jonathan Poole | Conselheiro | 29 de Maio de 2026 A | 2.010 | 0 | 0 | $0 |
| James M Daly | Conselheiro | 29 de Maio de 2026 A | 12.148 | 0 | 0 | $0 |
| Laura Brege | Conselheiro | 29 de Maio de 2026 A | 23.202 | 0 | 0 | $0 |
| Edmund Harrigan | Conselheiro | 29 de Maio de 2026 A | 43.148 | 0 | 0 | $0 |
| Daniel B Soland | Conselheiro | 1 de Junho de 2023 A | 28.002 | 0 | 0 | $0 |
| Torsten Rasmussen | Conselheiro | 11 de Junho de 2010 A | 4.000 | 0 | 0 | $0 |
| Leslie L Iversen | Conselheiro | 11 de Junho de 2010 A | 9.000 | 0 | 0 | $0 |
| Mary Ann Gray | Conselheiro | 11 de Junho de 2010 A | — | 0 | 0 | $0 |
| Michael T Borer | Conselheiro | 11 de Junho de 2010 A | — | 0 | 0 | $0 |
| Lester J Ph D Kaplan | Conselheiro | 11 de Junho de 2010 A | 4.000 | 0 | 0 | $0 |
| Gordon M Binder | Conselheiro | 12 de Junho de 2009 A | 14.364 | 0 | 0 | $0 |
| Alan G Walton | Conselheiro | 12 de Junho de 2009 A | 25.979 | 0 | 0 | $0 |
| Martien Van Osch | Conselheiro | 10 de Junho de 2005 A | 1.168.892 | 0 | 0 | $0 |
| GORDON CARL L | Conselheiro | 20 de Abril de 2005 A | 774.006 | 0 | 0 | $0 |
| Mark C. Schneyer | — | 6 de Agosto de 2026 M | 67.828 | 0 | 3 | $-587.248 |
| John Joseph Kaiser | — | 20 de Outubro de 2008 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 6 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 declarações | 26 de Fevereiro de 2026 | 25,40% | Emenda | — | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 declarações | 6 de Junho de 2013 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 2 de Maio de 2005 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 2 de Maio de 2005 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 2 de Maio de 2005 | — | Declaração inicial | — | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 29 de Abril de 2005 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 77 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,89% | 13.265 SH | 8 de Agosto de 2026 | Diário |
| PBE · Invesco Exchange-Traded Fund Trust | 3,29% | 407.914 SH | 8 de Agosto de 2026 | Diário |
| SBIO · ALPS ETF Trust | 2,35% | 175.740 NS | 31 de Maio de 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,87% | 109.972 SH | 8 de Agosto de 2026 | Diário |
| BBP · ETFis Series Trust I | 1,32% | 34.855 NS | 30 de Abril de 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,25% | 59.514 SH | 8 de Agosto de 2026 | Diário |
| LABU · Direxion Shares ETF Trust | 0,85% | 195.542 NS | 30 de Abril de 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,56% | 13.607 NS | 30 de Abril de 2026 | N-PORT |
| IJT · iShares Trust | 0,40% | 1.176.933 SH | 8 de Agosto de 2026 | Diário |
| OASC · Unified Series Trust | 0,39% | 15.269 NS | 31 de Maio de 2026 | N-PORT |
| IBB · iShares Trust | 0,37% | 1.239.145 SH | 8 de Agosto de 2026 | Diário |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,35% | 150.827 SH | 8 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,34% | 9.317 SH | 8 de Agosto de 2026 | Diário |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,27% | 61.606 NS | 30 de Abril de 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,24% | 24.003 NS | 31 de Maio de 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,23% | 20.369 SH | 8 de Agosto de 2026 | Diário |
| IWO · iShares Trust | 0,23% | 1.166.817 SH | 8 de Agosto de 2026 | Diário |
| XJR · iShares Trust | 0,23% | 14.974 SH | 8 de Agosto de 2026 | Diário |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 89.945 NS | 31 de Maio de 2026 | N-PORT |
| IJR · iShares Trust | 0,20% | 7.728.433 SH | 8 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 137.860 SH | 8 de Agosto de 2026 | Diário |
| BIB · ProShares Trust | 0,19% | 6.303 NS | 31 de Maio de 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,17% | 443.221 SH | 8 de Agosto de 2026 | Diário |
| BKSE · BNY Mellon ETF Trust | 0,17% | 6.035 NS | 30 de Abril de 2026 | N-PORT |
| SMMV · iShares Trust | 0,17% | 17.063 SH | 8 de Agosto de 2026 | Diário |
| SMLF · iShares Trust | 0,15% | 219.745 SH | 8 de Agosto de 2026 | Diário |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 47.683 NS | 30 de Abril de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 137.072 SH | 8 de Agosto de 2026 | Diário |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 81.552 NS | 30 de Abril de 2026 | N-PORT |
| SAA · ProShares Trust | 0,12% | 1.498 NS | 31 de Maio de 2026 | N-PORT |
| IWM · iShares Trust | 0,12% | 3.281.125 SH | 8 de Agosto de 2026 | Diário |
| ISCG · iShares Trust | 0,11% | 39.884 SH | 8 de Agosto de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 741.237 SH | 8 de Agosto de 2026 | Diário |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,09% | 66.331 SH | 8 de Agosto de 2026 | Diário |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.699.377 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,09% | 115.210 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,08% | 526.641 NS | 30 de Abril de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 16.957 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,07% | 5.921 NS | 31 de Maio de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 599.784 NS | 31 de Maio de 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 5.636 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 54.956 NS | 30 de Abril de 2026 | N-PORT |
| IEUS · iShares Trust | 0,04% | 7.411 SH | 8 de Agosto de 2026 | Diário |
| SMDX · Tidal Trust III | 0,04% | 2.306 NS | 30 de Abril de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4.033 SH | 8 de Agosto de 2026 | Diário |
| UWM · ProShares Trust | 0,04% | 4.631 NS | 31 de Maio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.457.036 SH | 8 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2.944.095 SH | 8 de Agosto de 2026 | Diário |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,04% | 14.209 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,04% | 346.329 SH | 8 de Agosto de 2026 | Diário |